SML0282

Bexarotene

Name: Bexarotene
Brand: SIGMA

≥98% (HPLC), retinoid X receptor (RXR) agonist, powder

Synonym(s):

4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid, LGD-1069, SR-11247

Select a Size

All Photos(1)

About This Item

Empirical Formula (Hill Notation):

C₂₄H₂₈O₂

CAS Number:

153559-49-0

Molecular Weight:

348.48

UNSPSC Code:

41106305

PubChem Substance ID:

329825290

NACRES:

NA.77

MDL number:

MFCD00932428

Product Name

Bexarotene, ≥98% (HPLC)

SMILES string

C=C(C1=CC=C(C(O)=O)C=C1)C2=C(C)C=C3C(C(C)(C)CCC3(C)C)=C2

InChI

1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)

InChI key

NAVMQTYZDKMPEU-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: ≥15 mg/mL (warmed)

storage temp.

−20°C

Application

Bexarotene has been used as retinoid x receptor (RXR) agonist:

to study its effect on human oral squamous cell carcinoma (OSCC) cell lines
to test for cooperative cell killing of cutaneous T cell lymphoma (CTCL) with 966
as a standard in HPLC for determining its potential impurities in drug substances and drug products

Bexarotene has been used:

to investigate its effects on the changes in renal, cardiac, hepatic, and pulmonary expression/activity of inducible nitric oxide synthase (iNOS) and CYP4F6
to analyze the involvement of retinoid x receptor (RXR) homo or permissive heterodimers
to study its potential impurities in drug substances and drug products

Biochem/physiol Actions

Bexarotene is a highly selective retinoid X receptor (RXR) agonist and an antineoplastic agent.

Bexarotene is a highly selective retinoid X receptor (RXR) agonist. It is an antineoplastic agent, already approved as an oral antineoplastic agent for cutaneous T cell lymphoma and being investigated against other cancers. A study has found that bexarotene in a mouse Alzheimer′s model lowered the most toxic form of β-amyloid peptide and increased cognitive ability. The activity in the mouse Alzheimer′s models are believed to be by activating PPARγ:RXR and LXR:RXR dimers which induces the expression of apoE and facilitates Aβ clearance and promotes microglial phagocytosis.

Bexarotene is used to treat breast cancer.

Features and Benefits

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Nuclear Receptors (Non-Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells

Osei-Sarfo K, et al.

PLoS ONE, 14(4), e0215234-e0215234 (2019)

Development and Validation of a Stability-Indicating LC Method for Determination of Bexarotene in Softgel Dosage Formulation

Rao KL, et al.

Chromatographia, 80(8), 1211-1224 (2017)

Bexarotene, a Selective RXRalpha Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock

Tunctan B, et al.

Inflammation, 41(1), 337-355 (2018)

The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor

Li Y, et al.

Breast Cancer Research and Treatment, 128(3), 667-677 (2011)

Protective effects of retinoid x receptors on retina pigment epithelium cells

Ayala-Pena VB, et al.

Biochimica et Biophysica Acta - Molecular Cell Research, 1863(6), 1134-1145 (2016)

View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service